close

Enter

Log in using OpenID

Diclofenac Patches Market

embed
Diclofenac is nonsteroidal anti-inflammatory drug (NSAID), which works in reducing hormones that cause inflammation and pain in the body.
Diclofenac Patches Market - Size, Outlook, and
Opportunity Analysis, 2018-2026
Diclofenac is nonsteroidal anti-inflammatory drug (NSAID), which works in reducing hormones
that cause inflammation and pain in the body. Non-steroidal anti-inflammatory drugs (NSAIDs)
are the most widely used therapeutic class of analgesic compounds, indicated to use in relieving
post extraction pain. Diclofenac sodium is a commonly prescribed NSAID, which exhibits antiinflammatory, analgesic and anti-pyretic activity. Diclofenac transdermal patches are used to get
temporary relief of minor aches and pains of the muscle and joints that are applied directly to
the area of pain. Transdermal diclofenac patches are found to be more effective as compared to
the diclofenac tablets, owing to its once-daily application and lesser frequency of systemic
adverse effects. Transdermal patches have been developed to offer innovative drug delivery
system for diclofenac, with reduced incidence of systemic adverse effects due to lower plasma
concentrations. Diclofenac patches are designed to treat pain associated with conditions such as
gout, migraine, rheumatoid arthritis, sprains of muscles and joints and in mild to moderate
fever in some cases.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1792
Diclofenac Patches Market Drivers
Diclofenac patches market is expected to witness significant growth over the forecast period,
owing to high prevalence of chronic pain disease. According to the American Academy of Pain
Medicine (AAPM), in 2011, around 1.8 billion people suffered from chronic pain. Moreover, the
National Institutes of Health (NIH) estimates that one in 10 people in the U.S. suffer from
chronic pain. According to a study published in the British Medical Journal in 2016, nearly
one-third to half of the population in the U.K. suffers from chronic pain. Moreover, according
to the NIH estimates published in 2015 by the American Pain Society (APS), around 50 million
people in the U.S. suffered from chronic pain. Moreover, rising prevalence of pain and
increasing prevalence of diseases such as cancer and others are driving the diclofenac patches
market growth. For instance, according to the National Cancer Institute, in 2018, around
1,735,350 new cases of cancer are expected to be diagnosed in the U.S. and 609,640 people are
expected to die from the disease. Furthermore, according to the Cancer Atlas: 2017, there were
an estimated 14.1 million new cancer cases in 2012. Moreover, India, China and other East and
Central Asian countries accounted for nearly half of world’s new cancer cases and deaths, in
2017. In addition, according to the same source, by 2025, there will be an estimated 19.3
million new cancer cases and 11.4 million cancer deaths, in less developed regions.
Growing research developments in the NSAIDs to increase its effectiveness pain management
and to extend its application in various areas of medical field, will drive the diclofenac patches
market. For instance, a study published in the International Journal of Ophthalmology: April
2018, stated that, application of prophylactic non-steroidal anti-inflammatory drugs (NSAIDs) in
pre- and post-cataract surgery may help to reduce the severity and frequency of the
development of cystoid macular edema (CME) in the eyes of diabetic patients. Furthermore, in
November 2017, researchers at the Indian Institute of Technology (IIT) Hyderabad have
developed a novel skin patch which releases diclofenac at the target site in a controlled way in
such way that, there will be constant release of the drug for as long as 12 hours. In addition,
the drug has low half-life of one–two hours and therefor constant release for up to 12 hours
offers consistent efficiency of diclofenac for a longer period.
Report includes chapters which deeply display the following deliverable about industry :
• Diclofenac Patches Market Research Objective and Assumption
• Diclofenac Patches Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Diclofenac Patches Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Diclofenac Patches Market, By Regions
• Diclofenac Patches Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Diclofenac Patches Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Diclofenac Patches Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Diclofenac Patches Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Diclofenac Patches Market Restraint
Diclofenac patches shows increased risk of heart attack or stroke when applied for longer
duration than it prescribed, hindering the growth of diclofenac patches market size. NSAIDs
cause an increased risk of serious cardiovascular thrombotic events, including myocardial
infarction (MI) and stroke, which can be fatal. This risk may occur early in treatment and may
increase with duration of use. Diclofenac patches also associated with major to minor side
effects including abnormal pain, constipation, nausea and vomiting, skin rash and tinnitus.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1792
Diclofenac Patches Market - Regional Analysis
On the basis of region, global diclofenac patches market is segmented into North America, Latin
America, Europe, Middle East, Asia Pacific, and Africa. North America holds dominant position
in diclofenac patches market, owing to the higher prevalence of strains, sprains of muscle and
joints, in this region. According to the National Health Statistics Reports: November 2016, there
were an estimated 4,262 numbers of sprains and strains injury are reported in the U.S. between
2011 and 2014, which is also the major cause (41.4%) of natural injury in sports and
recreation-related injury episodes.
Diclofenac Patches Market – Competitive Landscape
Key players operating in the diclofenac patches market include Pfizer Inc., Cadila Healthcare,
GlaxoSmithKline Pharmaceuticals Ltd., Hisamitsu Pharmaceutical co. Inc. and Teikoku Seiyaku
Co., Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge200   documents Email
Document
Category
Health and Medicine
Views
10
File Size
123 KB
Tags
Diclofenac Patches Market, market
1/--pages
Report inappropriate content